About
About HMC
Senior Management
Marketing
Legal | Compliance
Fund Administration
Harbert Realty Services
HERO Foundation
Strategies
Real Assets
European Real Estate
Infrastructure
South Bay
Seniors Housing
U.S. Real Estate
Private Capital
Credit Solutions
Discovery Strategy
Growth Equity
Absolute Return
Pioneer Strategy
6Beacon Strategy
News
Corporate Responsibility
Careers
Contact
Investor Login
About
About HMC
Senior Management
Marketing
Legal | Compliance
Fund Administration
Harbert Realty Services
HERO Foundation
Strategies
Real Assets
European Real Estate
Infrastructure
South Bay
Seniors Housing
U.S. Real Estate
Private Capital
Credit Solutions
Discovery Strategy
Growth Equity
Absolute Return
Pioneer Strategy
6Beacon Strategy
News
Corporate Responsibility
Careers
Contact
Investor Login
Posts Tagged with:
Epinephrine
HGP – Richmond-based Kaléo Makes Deal with Walgreens to Stock Allergic Reaction Injector for Infants and Toddlers
July 12, 2019 |
Read more >
HGP – With Life-Threatening Allergies Diagnosed in Infancy, kaléo Announces Availability of First and Only FDA-Approved Epinephrine Auto-Injector (EAI) for Infants and Toddlers Weighing 16.5 to 33 Pounds (7.5 to 15 kilograms)
April 26, 2018 |
Read more >
HGP – U.S. FDA Grants Priority Review for an Epinephrine Auto-Injector in Development by Kaléo Specifically for Infants and Small Children
July 27, 2017 |
Read more >
HGP – Kaléo Announces 2017 U.S. Return Of Auvi-Q® (Epinephrine Injection, Usp) Auto-Injector For Life-Threatening Allergic Reactions
October 26, 2016 |
Read more >
View More Results